本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

阿尔尼拉姆制药公司

235.74
-26.4200-10.08%
盘后233.72-2.0200-0.86%19:19 EDT
成交量:188.16万
成交额:4.58亿
市值:305.18亿
市盈率:-108.19
高:259.16
开:257.14
低:235.57
收:262.16
数据加载中...
2025/03/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/21

重要事件披露

Form 8-K - Current report
2025/03/05

重要事件披露

Form 8-K - Current report
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/13

重要事件披露

Form 8-K - Current report
2025/02/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/08

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]